Really? Mazda vs. Jeep? Sporty minimalism vs. trail-hungry ruggedness? What kind of buyer would cross-shop a CX-50 and a Cherokee? We hear you, but humor us—they may not appear to be in direct ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Emily Hart Every time Emily publishes a story, you’ll get an alert straight to your inbox!

A ticket in Georgia won the $980 million Mega Millions jackpot on Nov. 14, 2025. Just three weeks later, a New Jersey ticket won a $90 million prize on Dec. 2. The jackpot has now reset to $50 million ...

Indian stock market bulls waited 14 long months for the Nifty 50 to reach a fresh record high. Although the index attempted multiple times in November to break the September 2024 highs, it finally ...

How did he get the tapes? 50 Cent addresses securing the unreleased and controversial footage in the Diddy Netflix documentary, ‘Sean Combs: The Rocking’. 'Sean Combs: The Reckoning' sparked ...

The idea of the 50-year mortgages flooded the news recently. It is the newest attempt by the Trump Administration to bring down housing costs, but I don’t think it was thought through entirely. On ...

Artur is a copywriter and SEO specialist, as well as a small business owner. In his free time, he loves to play computer games and is glad that he was able to connect his professional career with his ...

As Florida's population ages, the focus turns to preventive health strategies, to add quality to later years. Experts stressed regular physical activity and proper nutrition are critical for managing ...

Consumer Reports’ Annual Owner Satisfaction Survey can improve the chances of finding a compatible car match. How? Our survey data reveals whether, all things considered, owners would buy the same car ...

The Indian stock market ended in the negative on Monday, November 24, on profit booking across segments amid mixed global cues. Extending losses to the second consecutive session, the Sensex closed at ...

Cancer immunotherapy has proven efficacy in some cancer subtypes but it often fails to deliver clinically meaningful benefits to patients because their tumors are poorly immunogenic. A major goal of ...